PMID- 28342225
OWN - NLM
STAT- MEDLINE
DCOM- 20180430
LR  - 20191210
IS  - 1346-8138 (Electronic)
IS  - 0385-2407 (Linking)
VI  - 44
IP  - 8
DP  - 2017 Aug
TI  - Japanese version of the Family Dermatology Life Quality Index: Translation and 
      validation.
PG  - 914-919
LID - 10.1111/1346-8138.13831 [doi]
AB  - Skin conditions affect the quality of life (QoL) of patients and their family. To 
      assess family members' QoL, a questionnaire uniquely designed for family members 
      is necessary. We translated the Family Dermatology Life Quality Index (FDLQI), 
      originally created and validated by Basra et al., into Japanese, and evaluated 
      its reliability and validity. For psychometric evaluations, 150 dermatology 
      patients and their family members were included. The Japanese version of the 
      FDLQI showed high test-retest reliability (intraclass correlation 
      coefficient = 0.95) and internal consistency reliability (Cronbach's 
      alpha = 0.86). FDLQI scores significantly correlated with DLQI scores (r = 0.58, 
      P < 0.01, Spearman's rho) and global question (GQ) which measured the patient's 
      skin condition on a visual analog scale (r = 0.36, P < 0.01). Family members of 
      patients with inflammatory skin diseases showed higher FDLQI scores than those 
      with isolated lesions, but the difference was not statistically significant 
      (P = 0.062, Mann-Whitney U-test). Responsiveness to change was demonstrated in a 
      group in which the patient's skin condition was assessed as improved (n = 37, 
      r = 0.46, P < 0.01) but not in that in which it became worse. The difference of 
      the change between the two groups was statistically significant (P < 0.01). 
      Additionally, the change in FDLQI scores and GQ were significantly correlated 
      (r = 0.40, P < 0.01). Exploratory factor analysis suggested essential 
      unidimensionality of the instrument. We showed acceptable validity and 
      responsiveness of this Japanese version of FDLQI. Further clinical 
      epidemiological studies are required to confirm this.
CI  - (c) 2017 Japanese Dermatological Association.
FAU - Higaki, Yuko
AU  - Higaki Y
AUID- ORCID: 0000-0001-5314-8357
AD  - Institute of Women's Health, Tokyo, Japan.
AD  - Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan.
FAU - Tanaka, Masaru
AU  - Tanaka M
AD  - Department of Dermatology, Tokyo Women's Medical University Medical Center East, 
      Tokyo, Japan.
FAU - Futei, Yuko
AU  - Futei Y
AD  - Department of Dermatology, Ogikubo Hospital, Tokyo, Japan.
FAU - Kamo, Toshiko
AU  - Kamo T
AD  - Institute of Women's Health, Tokyo, Japan.
AD  - Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
FAU - Basra, Mohammad Khurshid Azam
AU  - Basra MKA
AD  - Department of Dermatology and Wound Healing, Division of Infection and Immunity, 
      Cardiff University School of Medicine, Cardiff, UK.
AD  - Department of Dermatology, Ashford and St Peter's Hospitals NHS Foundation Trust, 
      Chertsey and Ashford, UK.
FAU - Finlay, Andrew Yule
AU  - Finlay AY
AD  - Department of Dermatology and Wound Healing, Division of Infection and Immunity, 
      Cardiff University School of Medicine, Cardiff, UK.
LA  - eng
PT  - Journal Article
PT  - Validation Study
DEP - 20170324
PL  - England
TA  - J Dermatol
JT  - The Journal of dermatology
JID - 7600545
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Child
MH  - Child, Preschool
MH  - Family/*psychology
MH  - Female
MH  - *Health Status Indicators
MH  - Humans
MH  - Infant
MH  - Japan
MH  - Male
MH  - Middle Aged
MH  - Psychometrics
MH  - *Quality of Life
MH  - Reproducibility of Results
MH  - Severity of Illness Index
MH  - Skin Diseases/*psychology
MH  - *Translations
MH  - Young Adult
OTO - NOTNLM
OT  - Family Dermatology Life Quality Index
OT  - psychometric evaluations
OT  - quality of life
OT  - skin disease
OT  - validation
EDAT- 2017/03/28 06:00
MHDA- 2018/05/01 06:00
CRDT- 2017/03/26 06:00
PHST- 2016/10/13 00:00 [received]
PHST- 2017/02/06 00:00 [accepted]
PHST- 2017/03/28 06:00 [pubmed]
PHST- 2018/05/01 06:00 [medline]
PHST- 2017/03/26 06:00 [entrez]
AID - 10.1111/1346-8138.13831 [doi]
PST - ppublish
SO  - J Dermatol. 2017 Aug;44(8):914-919. doi: 10.1111/1346-8138.13831. Epub 2017 Mar 
      24.